Skip to main content

and
  1. No Access

    Article

    Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT

    Clinical information about thiotepa-based autologous stem cell transplantation (auto-SCT) outside the primary central nervous system lymphoma (PCNSL) field is sparse. In this registry-based retrospective study...

    L Sellner, A Boumendil, H Finel, S Choquet, G de Rosa in Bone Marrow Transplantation (2016)

  2. No Access

    Article

    FDG-PET/CT findings in systemic mastocytosis: a French multicentre study

    Mastocytosis is a clonal haematological disease characterized by uncontrolled proliferation and the activation of mast cells. The value of FDG-PET/CT (FDG-PET) in mastocytosis has yet to be determined.

    S. Djelbani-Ahmed, M. O. Chandesris in European Journal of Nuclear Medicine and M… (2015)

  3. No Access

    Article

    HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM

    Allogeneic hematopoietic stem cell transplantation (HSCT) is considered the only a curative treatment in patients with higher risk myelodysplastic syndrome (MDS), although demethylating agents (DMA) have been ...

    M Robin, R Porcher, L Adès, E Raffoux, M Michallet, S François, J-Y Cahn in Leukemia (2015)

  4. No Access

    Article

    Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML

    Allogeneic hematopoietic stem cell transplantation provides the best chance of long-term survival for patients with AML, but is associated with an unpredictable risk of treatment-related mortality. From Januar...

    M Sébert, R Porcher, M Robin, L Adès, N Boissel, E Raffoux in Bone Marrow Transplantation (2015)

  5. No Access

    Article

    Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS

    The impact of allelic HLA matching in patients with AML and myelodysplastic syndrome (MDS) who receive allogeneic PBSC after a reduced-intensity conditioning (RIC) regimen is unclear. From January 2000 to Dece...

    M Robin, R Porcher, L Adès, N Boissel, E Raffoux, A Xhaard in Bone Marrow Transplantation (2013)

  6. No Access

    Article

    Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients

    Fludarabine (FDR) therapy gives a response rate of about 30% in previously treated patients with Waldenström's macroglobulinemia (WM). The combination of FDR and cyclophosphamide (Cy) has been shown to be effe...

    J Tamburini, V Lévy, C Chaleteix, J P Fermand, A Delmer, L Stalniewicz, P Morel in Leukemia (2005)

  7. No Access

    Article

    Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?

    We determined bone marrow karyotype at diagnosis in four female acute myeloid leukemia (AML) or myelodysplasia patients, aged between 52 and 56 years. In each case, we observed chromosome rearrangement involvi...

    F Viguié, A Aboura, D Bouscary, S Ramond, A Delmer, G Tachdjian, J P Marie in Leukemia (2005)

  8. No Access

    Article

    FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

    S Camilleri-Broët, N Mounier, A Delmer, J Brière, O Casasnovas, L Cassard in Leukemia (2004)

  9. No Access

    Article

    Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases

    B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of growth arrested clonal B lymphocytes that undergo apoptosis when treated with fludarabine. To further explore the mechanism f...

    L Sanhes, R Tang, A Delmer, J A DeCaprio, F Ajchenbaum-Cymbalista in Leukemia (2003)

  10. No Access

    Article

    Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study

    Mantle cell lymphoma (MCL) is a distinct clinico-pathological entity with a poor prognosis. We have conducted a prospective study in patients with MCL to evaluate a therapeutic strategy in which CHOP polychemo...

    F Lefrère, A Delmer, F Suzan, V Levy, C Belanger, M Djabarri, B Arnulf, G Damaj in Leukemia (2002)

  11. No Access

    Article

    Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure

    Characteristics of treatment-induced cell cycle arrest are important for in vitro and in vivo sensitivity of acute myeloid leukemia (AML) cells to cytotoxic drugs. We analyzed the expression of the major G1 cell ...

    N Radosevic, A Delmer, R Tang, J-P Marie, F Ajchenbaum-Cymbalista in Leukemia (2001)

  12. No Access

    Article

    Has the prognosis of adult patients with acute myeloid leukemia improved over years? A single institution experience of 784 consecutive patients over a 16-year period

    We reviewed the reports of 784 consecutive patients admitted to our department for newly diagnosed acute myeloid leukemia (AML) over a 16-year period. Median, 5-year and 10-year overall survivals were 9.5 mont...

    M Baudard, A Beauchamp-Nicoud, A Delmer, B Rio, CM Blanc, R Zittoun, JP Marie in Leukemia (1999)

  13. No Access

    Article

    Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder

    The conjunction of clinical features, cell morphology and immunological characteristics allows an accurate diagnosis in most cases of B cell chronic lymphoproliferative disorders (CLD). However, the diagnosis ...

    V Levy, V Ugo, A Delmer, R Tang, S Ramond, JY Perrot, R Vrhovac, JP Marie in Leukemia (1999)

  14. No Access

    Chapter and Conference Paper

    Management of Fever in Adult Hematological Neutropenic Patients: Comparison of Tazocillin + Aminoside versus Ceftazidime + Aminoside in 466 Febrile Episodes

    Two successive studies comparing tazocilline (12 g piperacillin + 1.5 g tazobactam/ day) + aminoside (15 mg/k/day amikacin in the first trial, 3 mg/kg/d tobramycin in the second) to ceftazidime (3 g/day) + ami...

    J. P. Marie, Z. Marjanovic, A. Vekhoff, A. Bouvet, F. Chast in Acute Leukemias VII (1998)

  15. No Access

    Article

    Multidrug resistance gene expression in acute myeloid leukemia: Major prognosis significance for in vivo drug resistance to induction treatment

     The clinical significance of the multidrug resistance (MDR 1) gene phenotype was investigated in newly diagnosed AML and was compared with other clinical and biological prognostic factors in patients who receive...

    M. Hunault, D. Zhou, A. Delmer, S. Ramond, F. Viguié, M. Cadiou in Annals of Hematology (1997)

  16. No Access

    Chapter and Conference Paper

    Prediction of Induction and Duration of Complete Remission in Acute Myelogenous Leukemia: Value of Clonogenic Cell Properties

    The in vitro clonogenic assay in acute myelogenous leukemia (AML) has brought the possibility to study the proliferative and differentiating capacity of the clonogenic cells as well as their in vitro sensitivi...

    R. Zittoun, J. P. Marie, D. Brilhante, A. Delmer in Acute Leukemias (1987)

  17. No Access

    Chapter and Conference Paper

    Geothermics in Hainaut (Belgium)

    The Cretaceous basin in the Haine valley shows particular structural and other features, known today to be related to the presence of one or several evaporite layers in the subsurface.

    A. Delmer, Ph. Dom, V. Leclercq, P. Hiroux in Advances in European Geothermal Research (1980)